Sriram Venkataraman
CIK 1550642 · last filed 2023-01-30
Sriram Venkataraman is a corporate insider who has filed 12 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for RVLP, was dated Jan 30, 2023. Across all open-market trades the lifetime net is −$112.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $732.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$732.10M
4
12
-$112.04M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc (RVLP) Delisted | Director | 23,730,864 | $0.03 | $669.2K | $12.40M | 2 | 2023-01-30 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Director | 1,032,995 | $1.11 | $1.15M | $6.25M | 2 | 2020-11-23 |
| OptiNose, Inc. (OPTN) Delisted | Director | 10,136,374 | $9.60 | $97.31M | -$71.59M | 6 | 2020-06-12 |
| LNTH | Director | 7,004,395 | $104.52 | $732.10M | -$59.10M | 2 | 2017-03-21 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-30 | RVL Pharmaceuticals plc (RVLP) Delisted | Other (J) | −1,032,995 | $0 | EDGAR |
| 2022-08-09 | RVL Pharmaceuticals plc (RVLP) Delisted | Buy (P) | +8,000,000 | $12.40M | EDGAR |
| 2020-11-23 | RVL Pharmaceuticals plc (OSMT) Delisted | Other (J) | −4,936,926 | $0 | EDGAR |
| 2020-06-12 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | RVL Pharmaceuticals plc (OSMT) Delisted | Buy (P) | +1,250,000 | $6.25M | EDGAR |
| 2019-11-26 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −1,250,000 | -$11.46M | EDGAR |
| 2019-06-10 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-13 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −2,875,000 | -$60.13M | EDGAR |
| 2018-06-11 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-19 | OptiNose, Inc. (OPTN) Delisted | Mixed | +18,256,405 | $20.00M | EDGAR |